Boston Imaging Core Lab
Boston Imaging Core Lab provides expert radiology imaging assessment for pharmaceutical clinical trials and academic research, with deep specialization in musculoskeletal and osteoarthritis imaging, serving pharma clients including Pfizer, Regeneron, Merck KGaA, Servier, and Galapagos.
- Company typePrivate
- Founded2007
- HeadquartersBoston, United States
- Headcount11–50
- GTM typeB2B
- OfferingServices
What Boston Imaging Core Lab does
Boston Imaging Core Lab, LLC (BICL) is a specialized clinical trial imaging core laboratory founded in June 2007 in Boston by three Academic Radiologists from Boston University School of Medicine. The company provides expert radiology image assessment services to pharmaceutical companies conducting clinical trials and to academic researchers running large musculoskeletal epidemiologic studies, with a flagship specialization in osteoarthritis and anti-nerve growth factor (aNGF) drug development.
BICL's core offering is human expert reading across six therapeutic areas: musculoskeletal imaging (with sub-focus on osteoarthritis, aNGF trials, and cartilage repair), neuroradiology, stroke, oncology and body imaging, pediatric imaging, and nuclear medicine and dosimetry. The technical platform combines clinical trial imaging using MRI, radiography, and nuclear medicine modalities with BICL's proprietary and co-developed semi-quantitative scoring systems (MOAKS, WORMS, BLOKS, KOSS, CROAKS, MOCART, RAMRIS) and complementary quantitative methods delivered through its 2009 partnership with Chondrometrics. BICL has cumulatively read over 30,000 time points from the NIH Osteoarthritis Initiative, 18,000+ from the Multicenter Osteoarthritis Study, and screened 23,079 patients across 480+ international sites in the Pfizer Tanezumab program, supported by 300+ peer-reviewed publications and a reader pool of 15 MSK academic radiologists including five full Professors of Radiology.
The business model is professional services on a project basis: quote-based enterprise contracts for clinical trial reading, eligibility screening, safety monitoring, and imaging protocol consulting, sold directly to pharmaceutical sponsors (Pfizer, Regeneron, Servier, Merck KGaA, Galapagos) and academic institutions, with secondary distribution through CRO partners (Clario, Calyx, Imaging Endpoints, Voiant Clinical) and imaging technology partners (Median Technologies, Keosys). Marketing is conducted primarily through scientific publications in Radiology, Osteoarthritis and Cartilage, and Seminars in Arthritis and Rheumatism, presentations at OARSI, ICRS, EULAR, and RSNA conferences, and engagement with FDA workshops on imaging biomarkers. An emerging AI/ML Support Services line provides expert annotations and clinical trial execution for third-party AI imaging products seeking FDA and EMA clearance.
Boston Imaging Core Lab firmographics
Firmographics- Name
- Boston Imaging Core Lab
- Legal name
- Boston Imaging Core Lab, LLC
- Website
- https://bicl.org
- Company type
- Private
- Founded year
- 2007
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Boston Imaging Core Lab provides expert radiology imaging assessment for pharmaceutical clinical trials and academic research, with deep specialization in musculoskeletal and osteoarthritis imaging, serving pharma clients including Pfizer, Regeneron, Merck KGaA, Servier, and Galapagos.
- Ownership category
- akta.pro rank
Boston Imaging Core Lab industry classification
Industry- Product category
- Clinical Trial Imaging Services
- NAICS
- Medical Laboratories (621511)
- SIC
- Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Imaging & Cardiac Safety Core Labs (ECOG/EEG/ECG) (HLAGAAAJ)
- akta.pro secondary industry
- Imaging Core Labs & Clinical Endpoint Adjudication (HLAGAEAH)
Keywords
Where Boston Imaging Core Lab is headquartered
LocationHeadquarters
- HQ city
- Boston
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Boston Imaging Core Lab business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Clinical Trial Imaging Services: Professional image assessment services provided to pharmaceutical companies for clinical trials, including reading services by expert musculoskeletal radiologists, consulting on imaging protocols, and quality control supervision.
Go-to-market motion1 record
Distribution channels3 records
Marketing channels3 records
Boston Imaging Core Lab product offering
Product offeringCore offering
Boston Imaging Core Lab (BICL) provides expert radiologist image assessment and consulting services for clinical trials and academic research. The lab specializes in musculoskeletal imaging (particularly osteoarthritis, anti-NGF studies, and cartilage repair) and extends services across neuroradiology, oncology and body imaging, pediatric imaging, nuclear medicine and dosimetry, stroke imaging, and AI/ML product validation for FDA and EMA clearance.
Product overview
Boston Imaging Core Lab (BICL) is a specialized clinical trial imaging core laboratory offering expert radiology reading and consulting services. The core offering consists of imaging assessment services across six therapeutic areas: Musculoskeletal Imaging (with focus on osteoarthritis, NGF-inhibitor studies, and cartilage repair), Neuroradiology Imaging, Oncology & Body Imaging, Pediatric Imaging, Nuclear Medicine & Dosimetry, and Stroke Imaging. Supporting the core services are specialized semiquantitative and quantitative assessment instruments including MOAKS (MRI Osteoarthritis Knee Score) for OA assessment, CROAKS (Cartilage Repair Osteoarthritis Knee Score) for cartilage repair evaluation, MOCART for repair tissue assessment, RAMRIS for rheumatoid arthritis, DCE-MRI and dGEMRIC for composition imaging, and quantitative JSW measurement. BICL also provides AI/ML support services including expert annotations for FDA/EMA validation and clinical trial design for AI product validation. The company serves pharmaceutical industry clients and academic researchers through clinical trial imaging services and scientific expertise.
Differentiator
Problem solved
Functional benefit
Quantifiable outcome
- 10.4% absolute gain in fracture detection sensitivity with AI assistance (64.8% to 75.2%)
- +4 more outcomes
Companies that use Boston Imaging Core Lab
Customer profileNamed customers5 records
Segments3 records
Ideal customer profiles1 record
Boston Imaging Core Lab technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability7 records
Feature6 records
Boston Imaging Core Lab partnerships and signals
Strategic signalPartnerships
Five partnerships are on record, tiered core and minor.
- ChondrometricscoreBICL and Chondrometrics formed a partnership in 2009 to broaden and advance their capabilities for offering imaging biomarker analysis. Together they offer a comprehensive portfolio of imaging biomarkers including both quantitative (Chondrometrics) and semi-quantitative (BICL) approaches that provide complementary and synergistic information in clinical trials.
- ClariominorClario provides clinical trial imaging services and partners with BICL for specialized musculoskeletal and osteoarthritis imaging reading services.
- CalyxminorCalyx provides imaging services for clinical trials and partners with BICL for specialized radiology reading services.
- Imaging EndpointsminorClinical trial imaging company that partners with BICL for specialized reading services.
- Voiant ClinicalminorClinical research services company that partners with BICL for specialized imaging reading capabilities.
Scale indicators7 records
Recent moves5 records
Expansion highlights5 records
Boston Imaging Core Lab competitors and assessment
Company assessmentDirect peers
- Median Technologies: Medical imaging company providing iCRO imaging services and AI-based image analysis for oncology clinical trials; directly comparable in trial-grade imaging reading and is a BICL channel partner.
- Calyx: Imaging core lab and clinical trial technology provider offering medical image management and central reading services; competes with BICL in central imaging reads for pharma trials and is listed as a BICL channel partner.
- Clario (formerly BioClinica): Full-service clinical trial imaging and endpoint solutions provider offering central reading, image management, and cardiac safety; directly overlaps BICL's core lab services and is listed as a BICL channel partner.
- Imaging Endpoints: Specialized clinical trial imaging core lab providing independent radiological review for oncology and other therapeutic areas; directly comparable to BICL as an independent imaging core lab serving pharma sponsors.
- Keosys: Imaging solution provider specializing in central imaging review and image management for clinical trials; directly overlaps BICL's core central reading services and is a BICL channel partner.
- Voiant Clinical: Clinical research services company with imaging reading capabilities for clinical trials; comparable to BICL in trial imaging reading and is a BICL channel partner.
Emerging players
- Chondrometrics: Quantitative cartilage, meniscus, and muscle MRI analysis provider partnered with BICL since 2009; closely comparable in MSK imaging biomarker services and shares joint go-to-market with BICL for OA trials.
- VirtualScopics (now part of Calyx): Quantitative imaging core lab specializing in biomarker-driven image analysis for clinical trials; comparable in trial imaging analysis and now integrated into Calyx's broader imaging platform.
Broad incumbents
- ICON plc: Global CRO offering comprehensive clinical trial services including imaging and central reading; represents broad incumbent competition with full-service bundling that BICL cannot match independently.
- Parexel: Global CRO with imaging and central reading capabilities integrated into full-service clinical trial delivery; comparable on the imaging core lab dimension but with substantially broader scope and scale.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks5 records
Key highlights7 records
Customer concentration
Boston Imaging Core Lab social profiles
Digital presenceBoston Imaging Core Lab financial estimates
Financial estimateRevenue estimate
Valuation estimate
Boston Imaging Core Lab leadership team
Management profileNumber of profiles
Profiles3 records
Boston Imaging Core Lab funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Boston Imaging Core Lab M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Boston Imaging Core Lab
What does Boston Imaging Core Lab do?
Boston Imaging Core Lab (BICL) provides expert radiologist image assessment and consulting services for clinical trials and academic research. The lab specializes in musculoskeletal imaging (particularly osteoarthritis, anti-NGF studies, and cartilage repair) and extends services across neuroradiology, oncology and body imaging, pediatric imaging, nuclear medicine and dosimetry, stroke imaging, and AI/ML product validation for FDA and EMA clearance.
Is Boston Imaging Core Lab a public or private company?
Boston Imaging Core Lab is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Boston Imaging Core Lab founded?
Boston Imaging Core Lab was founded in 2007. It employs 11 to 50 people.
Where is Boston Imaging Core Lab based?
Boston Imaging Core Lab is headquartered in Boston, United States, in the North America region.
How does Boston Imaging Core Lab make money?
One revenue line is on record: clinical Trial Imaging Services.
Who are Boston Imaging Core Lab's main competitors?
Direct peers on record are Median Technologies, Calyx, Clario (formerly BioClinica), Imaging Endpoints, Keosys and Voiant Clinical. Emerging players are Chondrometrics and VirtualScopics (now part of Calyx). Broad incumbents are ICON plc and Parexel.
Does Boston Imaging Core Lab have an API?
No public API is recorded for Boston Imaging Core Lab.
What industry is Boston Imaging Core Lab in?
Boston Imaging Core Lab's product category is Clinical Trial Imaging Services. Its primary akta.pro industry code is HLAGAAAJ, Imaging & Cardiac Safety Core Labs (ECOG/EEG/ECG), with a secondary code of HLAGAEAH, Imaging Core Labs & Clinical Endpoint Adjudication. Its NAICS code is 621511 and its SIC code is 8731.